SI
SI
discoversearch

Technology Stocks
MGNX -- MacroGenics
An SI Board Since November 2013
Posts SubjectMarks Bans Symbol
52 28 0 MGNX
Emcee:  scaram(o)uche Type:  Moderated
CD123-related abstract (preclinical) coming up at ASH, so maybe it's time for a thread. DART is a very old concept.... I was one of the first to try it, but the original concept came from Dartmouth and served as the foundation science for Medarex.

MGD006, Servier has right to license for some geographies.....

ash.confex.com

One more ASH abstract, not from MGNX.......

ash.confex.com

Pointer to the pipeline chart, website.....

macrogenics.com

Go!
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
52Bullish crossover in MACD and Stochastic oscillators. breakout watch over 18.58.hollyhunter-August 5
51>> bought back my August 17.5 puts for a modest profit << Cool.scaram(o)uche-August 4
50FWIW, on the pop of the last couple of days into this morning, I bought back my tuck-August 4
49Thanks for the chatter guys. I have nothing to add, except that the pipeline isscaram(o)uche-August 3
48The point is to do this ahead of P1 results (early), from competitive landscape tuck-August 3
47<I think it is worth waiting for the next year of data to come in before ratiMiljenko Zuanic-August 3
46The lowest dose with full potential for antitumor activity was 2 mg/kg Q3W Yes, tuck-August 3
45Keytruda: <Mechanism-based translational models with a focus on intratumor exMiljenko Zuanic-August 3
44EARLY, I WAS HOPING THAT PIPELINE WILL BRING FRUIT. Today, they should terminatMiljenko Zuanic1August 3
43MGA1012 (and other DART): This is 3X to 5X Opd/Key dose/regime! What the facxx tuck-August 3
42They are spending $~45M on R&D + G&A, so by now they should show some &qMiljenko Zuanic-August 2
41I think that is is about time to move pass DART hype & nonsense, and do someMiljenko Zuanic-August 2
40My mistake, there was data on 010 presented some weeks ago at EULAR, and it was tuck-August 2
39fwiw, I am very tempted at these levels. I have had two nice trips from 15 to 2mopgcw-August 2
38MGD006 Interim data at ESMO, with abstracts off embargo at five past midnight 8/tuck-August 2
37So far, mediocre volume trade after 1.1M share offer to Investor @21.5????Miljenko Zuanic-April 27
36>> MGA271 was well tolerated, with no dose-limiting toxicity and no maximscaram(o)uche-11/4/2015
35Just when I start to get excited about a late-breaker, Servier says "we'scaram(o)uche-10/28/2015
34Interim look, phase I trial? Late breaker, and it IS a 150 ptient trial. I wasscaram(o)uche-10/2/2015
33Lots of business plan progress, see PRs since 5/28. Today's news...... Macscaram(o)uche-7/15/2015
32MacroGenics Preclinical Research on MGD006 DART(R) Molecule Published in Sciencescaram(o)uche-5/28/2015
31<Janssen will invest $75M in MacroGenics via the purchase of 1,923,077 sharesBiotech Jim-12/22/2014
30MacroGenics Enters Collaboration and License Agreement with Janssen to Develop Mscaram(o)uche-12/22/2014
29Thanks Rick and Tuck. took profits here @ 34.50. look for another entry point.mopgcw-12/18/2014
28>>Patient enrollment continues in the Company's exploratory Phase 2a stuck-11/12/2014
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2017 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.